John Gribben
John Gribben
Professor of Medical Oncology, Queen Mary University of London
Adresse e-mail validée de qmul.ac.uk
Titre
Citée par
Citée par
Année
Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation
GJ Freeman, JG Gribben, VA Boussiotis, JW Ng, VA Restivo, LA Lombard, ...
Science 262 (5135), 909-911, 1993
11091993
ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia
LZ Rassenti, L Huynh, TL Toy, L Chen, MJ Keating, JG Gribben, ...
New England Journal of Medicine 351 (9), 893-901, 2004
10822004
Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma
JG Gribben, AS Freedman, D Neuberg, DC Roy, KW Blake, SD Woo, ...
New England Journal of Medicine 325 (22), 1525-1533, 1991
8071991
Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation
CD Gimmi, GJ Freeman, JG Gribben, G Gray, LM Nadler
Proceedings of the National Academy of Sciences 90 (14), 6586-6590, 1993
7071993
B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.
CD Gimmi, GJ Freeman, JG Gribben, K Sugita, AS Freedman, C Morimoto, ...
Proceedings of the National Academy of Sciences 88 (15), 6575-6579, 1991
5521991
Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug
AG Ramsay, AJ Johnson, AM Lee, G Gorgün, R Le Dieu, W Blum, JC Byrd, ...
The Journal of clinical investigation 118 (7), 2427-2437, 2008
5512008
Transplantation of anergic histoincompatible bone marrow allografts
EC Guinan, VA Boussiotis, D Neuberg, LLV Brennan, N Hirano, ...
New England Journal of Medicine 340 (22), 1704-1714, 1999
5171999
Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival
OM Howard, JG Gribben, DS Neuberg, M Grossbard, C Poor, MJ Janicek, ...
Journal of Clinical Oncology 20 (5), 1288-1294, 2002
4712002
Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity
EC Guinan, JG Gribben, VA Boussiotis, GJ Freeman, LM Nadler
4661994
Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.
GJ Freeman, GS Gray, CD Gimmi, DB Lombard, LJ Zhou, M White, ...
The Journal of experimental medicine 174 (3), 625-631, 1991
4581991
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
J Okosun, C Bödör, J Wang, S Araf, CY Yang, C Pan, S Boller, D Cittaro, ...
Nature genetics 46 (2), 176-181, 2014
4472014
Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production.
GJ Freeman, F Borriello, RJ Hodes, H Reiser, JG Gribben, JW Ng, J Kim, ...
The Journal of experimental medicine 178 (6), 2185-2192, 1993
4381993
Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma
AS Freedman, D Neuberg, P Mauch, RJ Soiffer, KC Anderson, DC Fisher, ...
Blood, The Journal of the American Society of Hematology 94 (10), 3325-3333, 1999
4161999
Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997
MR Grever, DM Lucas, GW Dewald, DS Neuberg, JC Reed, S Kitada, ...
Journal of Clinical Oncology 25 (7), 799-804, 2007
4132007
Chronic lymphocytic leukaemia
TJ Kipps, FK Stevenson, CJ Wu, CM Croce, G Packham, WG Wierda, ...
Nature reviews Disease primers 3 (1), 1-22, 2017
398*2017
All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation …
JG Gribben, AS Freedman, SD Woo, K Blake, RS Shu, G Freeman, ...
3981991
CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.
JL Schultze, S Michalak, MJ Seamon, G Dranoff, K Jung, J Daley, ...
The Journal of clinical investigation 100 (11), 2757-2765, 1997
3911997
Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
DC Taussig, F Miraki-Moud, F Anjos-Afonso, DJ Pearce, K Allen, C Ridler, ...
Blood, The Journal of the American Society of Hematology 112 (3), 568-575, 2008
3832008
Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation …
JG Gribben, D Neuberg, AS Freedman, CD Gimmi, KW Pesek, M Barber, ...
3811993
CTLA4 mediates antigen-specific apoptosis of human T cells
JG Gribben, GJ Freeman, VA Boussiotis, P Rennert, CL Jellis, ...
Proceedings of the National Academy of Sciences 92 (3), 811-815, 1995
3611995
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20